A prospective, single arm, open label, single centre clinical study to evaluate the safety and efficacy of Nimson Almond oil in Dandruff and Hairfall control - NI

Aryanveda Cosmeceuticals0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1. Subjects aged between 18 to 65 years.
•2. Subjects who willing to give written informed consent and ready to comply with the protocol.
•3. Subjects with active alopecia, seborrheic dermatitis of the scalp – Total ASFS Score = 16
•4. Subjects with a minimum hair length of 2 inches and willing to maintain the same minimum length,
•hair style until the end of the study.

•1. Subjects on topical treatment for alopecia and seborrheic dermatitis for 8 weeks prior to
•enrollment.
•2. Subject with other dermatological disorders of the scalp that might interfere with the study
•evaluation.
•3. Subjects with significant scalp scarring.
•4. Subjects who have anemia or iron deficiency.
•5. Subjects who have previously undergone hair transplantation procedures.
•6. History of systemic or cutaneous malignancy or evidence of immunocompromised state.
•7. Subjects with history of skin allergy.
•8. Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
•9. Female subjects who are reported pregnant/planning a pregnancy or lactating.
•10. Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrollment.
•11. Subjects, who in the opinion of the Investigator or the Expert Dermatologist are not eligible for enrollment in the study.

发起方

Aryanveda Cosmeceuticals